⋮
0
0
武田宣布mobocertinib (TAK-788)获美国FDA突破性治疗药物认证，用于治疗EGFR外显子20插入突变型NSCLC患者
Showing live article 1457 of 3352 in channel 19681208
Article Details:
Author:
Language: Japanese
Channel Number: 19681208
Article Number: 1457
Date: April 28, 2020, 4:26 pm
URL: http://www.qlifepro.com/press/20200429-17-56002/takeda-pharmaceutical-233/
GUID: http://www.qlifepro.com/press/?p=56002
←
$
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
0
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL